Malcolm Feigen, MD
Heidelberg Reparation Hospital, Australia
Dr. Malcolm Feigen radiation oncologist working in Melbourne, Australia who began using high dose radiotherapy to palliate mesothelioma patients in 2003 after meeting Dr Craig Stevens from MD Anderson Cancer Center. As the thoracic surgeons at his institution were reluctant to perform pneumonectomies, he began using radiotherapy to delay recurrences after pleurectomy/decortications with photodynamic therapy in patients who were not given chemotherapy, and performed PET/CT scans to define the active disease regions before planning their radiotherapy. Many patients returned for follow up PET scans and, as few experienced radiotherapy complications, he gradually expanded the treatment field using more advanced radiotherapy technologies, and is currently offering intensity-modulated radiotherapy to the whole hemithorax in selected patients with advanced mesotheliomas who have not had the involved lung removed. There have been no significant toxicities with doses up to 60 Gy in six weeks, and PET scans performed up to five years after radiotherapy have shown long term local control.
Kenneth Rosenzweig, MD
Memorial Sloan-Kettering Cancer Center
Dr. Kenneth Rosenzweig is a radiation oncologist at Memorial Sloan-Kettering Cancer Center with clinical expertise in treating cancers of the chest: non-small cell lung cancer, small cell lung cancer, mesothelioma, and thymoma. His research involves adapting the latest technology to allow for safer, more aggressive radiation therapy for lung cancer.
To view this video presentation, please click on the image below.